Use of TrkB antibodies for the treatment of respiratory disorders

Details for Australian Patent Application No. 2008316474 (hide)

Owner Novartis AG

Inventors Blaustein, Cecile

Agent Davies Collison Cave

Pub. Number AU-A-2008316474

PCT Pub. Number WO2009/053442

Priority 60/981,851 23.10.07 US

Filing date 23 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/053442 Priority application(s): WO2009/053442

23 September 2010 Amendment Made

  The nature of the amendment is:Add coinventor Glass, Sarah

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008316476-Compounds of 2,3-dihydro-benzofuran

2008316473-Phenylpyrrolidine compounds